Advertisement
Advertisement

LPCN

LPCN logo

Lipocine Inc.

2.47
USD
Sponsored
-0.06
-2.37%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

2.43

-0.04
-1.62%

LPCN Earnings Reports

Positive Surprise Ratio

LPCN beat 28 of 42 last estimates.

67%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$165.75K
/
-$0.44
Implied change from Q1 26 (Revenue/ EPS)
+38.82%
/
-18.52%
Implied change from Q2 25 (Revenue/ EPS)
-73.39%
/
+7.32%

Lipocine Inc. earnings per share and revenue

On May 07, 2026, LPCN reported earnings of -0.54 USD per share (EPS) for Q1 26, missing the estimate of -0.49 USD, resulting in a -9.16% surprise. Revenue reached 119.40 thousand, compared to an expected 165.75 thousand, with a -27.96% difference. The market reacted with a -1.65% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.44 USD, with revenue projected to reach 165.75 thousand USD, implying an decrease of -18.52% EPS, and increase of 38.82% in Revenue from the last quarter.
FAQ
For Q1 2026, Lipocine Inc. reported EPS of -$0.54, missing estimates by -9.16%, and revenue of $119.40K, -27.96% below expectations.
The stock price moved down -1.65%, changed from $2.43 before the earnings release to $2.39 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 3 analysts, Lipocine Inc. is expected to report EPS of -$0.44 and revenue of $165.75K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement